Table 6.
Postural outcome measurements Pre and Post treatment in patients and test re-test in the control group.
| Control day 1 mean | SD | Control day 2 mean | SD | Patient pre day 1 mean | SD | Patient post day 5 mean | SD | p-value (unadjusted) | p-value (BF Corr.) | |
|---|---|---|---|---|---|---|---|---|---|---|
| AUC_ML | 0.09 | 0.1 | 0.16 | 0.31 | 0.64 | 1.06 | 0.1 | 0.12 | 0.083 | 0.415 |
| AUC_AP | 0.51 | 0.36 | 0.42 | 0.35 | 1.51 | 1.8 | −1.09 | 1.77 | ||
| CEA | 3.61 | 3.12 | 4.19 | 5.77 | 14.44 | 20.18 | 2.47 | 2.12 | 0.002 | 0.01 |
| Path Length | 132.07 | 42.74 | 128.42 | 44.19 | 82.76 | 65.68 | 58.34 | 35.56 | 0.028 | 0.14 |
| Velocity | 2.16 | 0.7 | 2.08 | 0.74 | 1.71 | 0.99 | 1.05 | 0.4 | 0.006 | 0.03 |
This table represents the mean and standard deviation (SD) of the case and control group at the two points of measurement. Significant p-values (bold) testing for a difference (using the Mann-Whitney U test) in test-re-test values between the two groups are reported. The last column shows the p-values after Bonferroni correction for 5 hypothesis tests. In bold text the statistical significant value. Abbreviations: AUC_AP, Area under curve Anterior-Posterior; AUC_ML, Area under the curve Medial-Lateral; CEA, Confidence Ellipse Area; BF Corr., Bonferroni Correction.